Among the proteolytic systems involved in cancer is the plasminogen activation (PA) system, which includes serine proteases as plasmin and the urokinase-type (uPA) and tissue-type (tPA) plasminogen activators, specific inhibitors, cellular receptors. This evidence concerns the gene PLG and cancer.